Can Generic Medications Stay Less Costly Than Branded Medications?
. But what is less know is the dosage may be a bit less well controlled. And it's also perhaps not as closely monitored for safety in what a Sept 11, 2013 JAMA editorial called less responsibility for 'pharmacovigilance'. The brand name drug has a defined set of responsibilities to report new safety findings, and the generics do not. Closer monitoring of generics, much like brand products is a goal of the future. But the funding for this will have to come though some fees. If generic drugs are to remain as safe as the branded products, then their costs may have to be more similar.